Literature DB >> 9840117

Two cases of gastric involvement of esophageal cancer: intramural metastasis and intramural lymph node metastasis.

N Koide1, K Yazawa, S Koike, W Adachi, J Amano, K Ishii.   

Abstract

Cases of esophageal cancer with intramural metastasis to the stomach and esophageal cancer with metastasis to an intramural lymph node of the stomach are herein reported. The former patient was a 52 year-old male. Squamous cell carcinoma (SCC) of the lower esophagus with an intramural metastasis located at the gastric cardia and a small leiomyoma at the fornix were resected. The latter patient was a 70 year-old female. SCC of the lower esophagus and an intramural lymph node metastasis located at the anterior wall of the gastric cardia were resected. The patient died nevertheless of multiple liver metastases. These gastric involvements were detectable by endoscopy before surgery. The clinicopathological features of these esophageal cancers were characterized; the sites were the lower part of the esophagus, and extreme lymphatic and vascular invasions were shown histologically. The gastric tumors were located in the upper third of the stomach, and the findings revealed submucosal tumors. It is therefore important to discriminate other gastric tumors, and to resect them simultaneously with esophageal cancer when a gastric tube has been used for reconstruction after esophagectomy.

Entities:  

Mesh:

Year:  1998        PMID: 9840117

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Esophageal squamous cell carcinoma with entirely intramural growth pattern.

Authors:  Burkhard H A von Rahden; Björn L D M Brücher; Mario Sarbia
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

2.  Esophageal papillomatosis complicated by squamous cell carcinoma.

Authors:  T Attila; A Fu; N Gopinath; C J Streutker; N E Marcon
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

Review 3.  Undervalued criteria in the evaluation of multimodal trials for upper GI cancers.

Authors:  Björn L D M Brücher; Masaki Kitajima; Jörg Rüdiger Siewert
Journal:  Cancer Invest       Date:  2014-09-24       Impact factor: 2.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.